Table 2 Univariate and multivariate analyses of prognostic factors for all-stage endometrial endometrioid carcinoma
Univariate analysis (progression-free survival) | Multivariate analysis (progression-free survival) | Univariate analysis (overall survival) | Multivariate analysis (overall survival) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Variables | HR | 95% CI | p-value | HR | 95% CI | p-value | HR | 95% CI | p-value | HR | 95% CI | p-value |
Age (<60 vs. ≥60 years) | 1.74 | 1.12–2.72 | 0.015 | 1.62 | 1.00–2.62 | 0.049 | ||||||
TP53 status (normal vs. aberrant) | 3.88 | 2.49–6.07 | <0.001 | 4.31 | 2.67–6.95 | <0.001 | ||||||
FIGO grade (G1/2 vs. G3) | 1.96 | 1.55–2.49 | <0.001 | 2.14 | 1.67–2.74 | <0.001 | ||||||
Prognostic grade (low vs. high) | 4.67 | 3.01–7.23 | <0.001 | 2.91 | 1.85–4.56 | <0.001 | 5.34 | 3.31–8.62 | <0.001 | 3.62 | 2.21–5.94 | <0.001 |
FIGO stage (I/II vs. III/IV) | 3.43 | 2.72–4.33 | <0.001 | 3.06 | 2.41–3.89 | <0.001 | 3.20 | 2.49–4.11 | <0.001 | 2.83 | 2.19–3.66 | <0.001 |
